MedPath

Postmarket Study of JUVÉDERM VOLBELLA™ With Lidocaine in the Lips

Completed
Conditions
Lip Augmentation
Interventions
Device: Crosslinked hyaluronic acid gel
Registration Number
NCT01629134
Lead Sponsor
Allergan Medical
Brief Summary

A prospective, multicenter postmarket study of the use of JUVÉDERM VOLBELLA™ with Lidocaine in the lips.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
62
Inclusion Criteria
  • Desire and willingness for correction of asymmetry or volume enhancement of his/her lips
  • Females and males ≥ 18 years of age
  • Have established a realistic treatment goal that the Physician agrees is achievable, i.e., have realistic expectations of aesthetic results
Exclusion Criteria
  • Not fulfilling the standard prescribing criteria for JUVÉDERM VOLBELLA™ with Lidocaine as detailed in the Directions for Use
  • Have a condition or be in a situation that, in the Physician's opinion, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
VolbellaCrosslinked hyaluronic acid gelSubjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use
Primary Outcome Measures
NameTimeMethod
Injector Rating of the Natural Look and Feel of the Lips4 weeks

Percentage of injectors who rated the look and feel of subjects' lips as being extremely natural, very natural, slightly natural, and not natural.

Subject Rating of the Natural Look and Feel of the Lips4 weeks

Percentage of subjects rating the look and feel of their lips as being extremely natural, very natural, slightly natural, and not natural.

Secondary Outcome Measures
NameTimeMethod
Ease of Injection15 minutes after injection

Injectors rated the ease of injection on a scale ranging from 0 (Very easy) to 10 (Extremely difficult)

Bruising of the Lips15 minutes after injection

Injector assessment of whether there was none, little, some, moderate, or considerable bruising in subjects' lips

Malleability of Product15 minutes after injection

Injectors rated the malleability on a scale ranging from 0 (Extremely malleable/Not hard to mold) to 10 (Not malleable/Hard to mold)

Need for Massage15 minutes after injection

Injectors rated whether none/minimal, a little, some, or a lot of massage was required to optimize placement of VOLBELLA

Return to Social Engagement4 weeks

Time to return to normal daily activities

Comparative Rating With Previous Treatment15 minutes after injection

Subject rating of lip improvement with VOLBELLA compared with previous lip enhancement treatments as significantly better, somewhat better, no difference, somewhat worse, or significantly worse

Swelling of the Lips15 minutes after injection

Injector assessment of whether there was none, little, some, moderate, or considerable swelling in subjects' lips

Rating of Injection Discomfort15 minutes after injection

The level of discomfort during treatment on a scale of 0 (no discomfort) to 10 (extreme discomfort).

© Copyright 2025. All Rights Reserved by MedPath